| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming. | Clin Cancer Res | 2007 | 1.01 |
| 2 | Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells. | Clin Cancer Res | 2012 | 0.91 |
| 3 | Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer. | Ann N Y Acad Sci | 2009 | 0.80 |